oxybutynin chloride
NDC 16729-317, oxybutynin chloride, tablet, extended release, from Accord Healthcare, Inc..
- Product NDC
- 16729-317
- Status
- Listed
- Labeler
- Accord Healthcare, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207138
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-317-01 | 16729031701 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-01) |
| 16729-317-16 | 16729031716 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-16) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/61496a1e-17bf-4f45-a20c-5bb98fe545eeNADAC price for package 16729031716
GET /v1/drugs/nadac/16729031716
Use it
Look up 16729-317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.